Salivary Metabolomics for Oral Precancerous Lesions: A Comprehensive Narrative Review

Abstract

Oral submucous fibrosis (OSMF) is a chronic, potentially malignant disorder of the oral cavity, primarily associated with the consumption of areca nut products and other risk factors. Early and accurate diagnosis of OSMF is crucial to prevent its progression to oral cancer. In recent years, the field of metabolomics has gained momentum as a promising approach for disease detection and monitoring. Salivary metabolomics, a non-invasive and easily accessible diagnostic tool, has shown potential in identifying biomarkers associated with various oral diseases, including OSMF.

This review synthesizes current literature on the application of salivary metabolomics in the context of OSMF detection. The review encompasses a comprehensive analysis of studies conducted over the past decade, highlighting advancements in analytical techniques, metabolomic profiling, and identified biomarkers linked to OSMF progression. The primary objective of this review is to provide a critical assessment of the feasibility and reliability of salivary metabolomics as a diagnostic tool for OSMF, along with its potential to differentiate OSMF from other oral disorders.

In conclusion, salivary metabolomics holds great promise in revolutionizing OSMF detection through the identification of reliable biomarkers and the development of robust diagnostic models. However, challenges such as sample variability, validation of biomarkers, and standardization need to be addressed before its widespread clinical implementation. This review contributes to a comprehensive understanding of the current status, challenges, and future directions of salivary metabolomics in the realm of OSMF detection, emphasizing its potential impact on early intervention and improved patient outcomes.